Addressing Clinical Trial Diversity: Challenges, Opportunities, and Critical Capabilities
The 2024 SCOPE Europe conference featured a presentation on clinical trial diversity, highlighting the critical need for diversity and...
Moe Alsumidaie
Advancing Immunotherapy: Insights from Ymmunobio CEO
In this discussion, Moe Alsumidaie interviews Peter Schiemann, CEO and Chairman of Ymmunobio, about the company’s innovative approaches to...
Unleashing Patient Insights: Transforming Clinical Trials with Patient Perspectives
At SCOPE Summit Europe 2024, industry leaders gathered to explore the transformative potential of patient perspectives in decentralized clinical...
Exploring Innovative Approaches in Alzheimer’s and Dementia Treatment
In this insightful discussion, we interview Anthony Caggiano, Chief Medical Officer and Lisa Ricciardi, CEO, of Cognition Therapeutics about...
Accelerating ALS Research: Insights from the ALS Association
In this interview, we speak with Dr. Kuldip Dave from the ALS Association to explore their strategic approach to...
Roche Innovative Approach to Data-Driven Site Selection in Clinical Trials
In a groundbreaking presentation at SCOPE Europe 2024, Susannah Finney, Clinical Operations Lead and Product Owner at Roche, UK,...
Enhancing Patient Engagement in Clinical Trials: Insights from Medable
In a recent discussion with Jena Daniels, VP of Patient Success at Medable, we explored the company’s recognition as...
Navigating Challenges in Sexual Health Innovation with Morari Medical
In this interview, we speak with Jeff Bennett, CEO of Morari Medical, about the challenges and strategies in developing...
Transforming Cardiac Imaging with AI: An Interview with UltraSight Davidi Vortman
In this interview, we speak with Davidi Vortman, CEO of UltraSight, about their innovative AI-driven ultrasound technology and how...
Mass General Brigham on Enhancing Clinical Trials: The Critical Role of Study Sites in Protocol Design
The design of a study’s protocol is pivotal to its success in clinical trials, and engaging study sites early...